Allist(SH:688578) Zhong Guo Jing Ji Wang·2025-08-11 05:49Core Viewpoint - The company announced a share reduction plan by its shareholders, which will not affect the company's control or governance structure [1] Group 1: Share Reduction Plan - Shanghai Aixiang and Nantong Aiyun plan to reduce their holdings by a total of up to 13,500,000 shares, representing no more than 3.00% of the company's total share capital [1] - The reduction will occur through block trades and centralized bidding, with a maximum of 4,500,000 shares (1.00%) through centralized bidding and 9,000,000 shares (2.00%) through block trades [1] - The shareholders involved in this reduction are employee shareholding platforms, and the plan is set to begin on September 1, 2025, lasting for three months [1] Group 2: Share Reduction Results - From September 30, 2024, to October 29, 2024, Shanghai Aixiang and Nantong Aiyun successfully reduced their holdings by 4,500,000 shares at a price range of 46.50 to 55.18 yuan per share, totaling 219,798,490 yuan [2][3] - After the reduction, the current holding of Shanghai Aixiang and Nantong Aiyun is 42,701,022 shares [3] Group 3: Company Background - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 2, 2020, with an issuance of 90 million shares at a price of 22.73 yuan per share [4] - The total amount raised by the company was 2,045.70 million yuan, with a net amount of 1,932.55 million yuan after deducting issuance costs [4] - The funds raised are allocated for various projects, including new drug research and development, headquarters and research base construction, marketing network development, and information technology projects [4]